LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis

BACKGROUND: Ovarian cancer (OC) is a high-mortality gynecological cancer that is typically treated with cisplatin, although such treatment often results in chemoresistance. Ovarian cancer resistance is usually related to cell stemness. Herein, we explored the function of lncRNA WDFY3-AS2 in OC cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yue, Wang, Ting, Xia, Lin, Zhang, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164817/
https://www.ncbi.nlm.nih.gov/pubmed/34051810
http://dx.doi.org/10.1186/s12935-021-01993-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164817/
https://www.ncbi.nlm.nih.gov/pubmed/34051810
http://dx.doi.org/10.1186/s12935-021-01993-x

Ejemplares similares